CIBC Private Wealth Group
ADMA icon

CIBC Private Wealth Group’s ADMA Biologics ADMA Stock Holding History

CIBC Private Wealth Group’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$158K Buy
8,666
+59
+0.7% +$994 ﹤0.01% 1305
2025
Q3 		$126K Sell
8,607
-158
-2% -$2.71K ﹤0.01% 1389
2025
Q2 		$160K Sell
8,765
-639
-7% -$13K ﹤0.01% 1209
2025
Q1 		$168K Buy
9,404
+4,296
+84% +$74.3K ﹤0.01% 1139
2024
Q4 		$94.8K Buy
5,108
+2,954
+137% +$55.6K ﹤0.01% 1440
2024
Q3 		$43.1K Sell
2,154
-7,365
-77% -$115K ﹤0.01% 1826
2024
Q2 		$111K Sell
9,519
-10,426
-52% -$87.5K ﹤0.01% 1361
2024
Q1 		$130K Sell
19,945
-9,518
-32% -$52K ﹤0.01% 1287
2023
Q4 		$133K Buy
29,463
+6,473
+28% +$23.9K ﹤0.01% 1091
2023
Q3 		$82.3K Buy
+22,990
New +$88.5K ﹤0.01% 1041

Other funds holding ADMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

CIBC Private Wealth Group's ADMA Position: Q4 2025 in Review

CIBC Private Wealth Group increased its ADMA Biologics (ADMA) stake by 0.69% in Q4 2025, buying an estimated $994 and bringing the position to 8,666 shares worth $158K. The position accounts for ﹤0.01% of the portfolio, ranked #1305.

CIBC Private Wealth Group first reported a position in ADMA in Q3 2023 and has held it in 10 quarters since. The position peaked at $168K in Q1 2025. 356 funds tracked by Wall St. Rank hold ADMA as of Q4 2025.

  • CIBC Private Wealth Group held 8,666 shares of ADMA Biologics worth $158K as of Q4 2025.
  • CIBC Private Wealth Group bought 59 ADMA Biologics shares in Q4 2025, an estimated $994.
  • ADMA Biologics made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #1305 holding.
  • CIBC Private Wealth Group first reported a position in ADMA Biologics in Q3 2023 and has held it in 10 quarters since.
  • CIBC Private Wealth Group's ADMA Biologics position peaked at $168K in Q1 2025.
  • 356 funds tracked by Wall St. Rank held ADMA Biologics as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.